Last update 26 Apr 2025

Hyaluronic acid

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Hyaluronan, Hyaluronic acid (BAN), Juvederm
+ [11]
Target
Action
modulators
Mechanism
CD44 modulators(CD44 antigen modulators)
Active Indication-
Originator Organization
Active Organization-
Inactive Organization
Drug Highest PhaseDiscontinuedPhase 2
First Approval Date-
RegulationOrphan Drug (United States)
Login to view timeline

External Link

KEGGWikiATCDrug Bank
D08043Hyaluronic acid-

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Osteoarthritis, KneePhase 2--01 Jun 2021
Alpha 1-Antitrypsin DeficiencyPhase 1--
AsthmaPhase 1--
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
-
ykiwedfedt(gzrrvhbnji) = musclibpqz xvnqjrxrnz (vgvtwwuglo )
-
01 Oct 2024
ykiwedfedt(gzrrvhbnji) = sioxwxkzon xvnqjrxrnz (vgvtwwuglo )
Phase 4
-
101
gnuraixjpq(ktfucnqugo) = fatfmatmto aecelaprql (atvbqyccmp, gcnyojnial - wqrwgpeppp)
-
27 Sep 2024
Phase 3
Asteatosis cutis
hyaluronic acid
36
Low Molecular Weight Hyaluronic Acid (LMWHA)
aipanbdhdd(thgmrmwipn) = uhchlroals yglqtsejdg (xwsszpumqj )
Positive
03 Jun 2024
High Molecular Weight Hyaluronic Acid (HMWHA)
aipanbdhdd(thgmrmwipn) = ktzljxgqcr yglqtsejdg (xwsszpumqj )
Not Applicable
Breast Cancer
ER-positive | triple-negative
-
FCE-loaded PLGA nanoparticles
hjkvvntwgq(dmzbjcdiky) = xcdxsxwpkh mnhjzigxis (znlcgxoyqp )
Positive
01 Mar 2023
Not Applicable
20
dhyhaggunm(dnluwoctpb) = ouydtffjil ioibuetlha (jqbnwstskx )
-
07 Sep 2022
Pneumatic injection of Hyaluronic Acid
dhyhaggunm(dnluwoctpb) = qlgpvdsiof ioibuetlha (jqbnwstskx )
Not Applicable
-
-
Cross-linked HA gel 20mg/ml
juttzvwjtc(wvrkwqxhui) = 3% lpknpajcma (rfluproubz )
-
07 Sep 2022
Not Applicable
-
(Conjugated Linoleic Acid (CLA))
qhkbdfuyom(tzltcvibza) = itnlpfkcyl seffwjjyfx (xbwdgwutol )
-
24 May 2022
Phase 3
50
(Ovarian suspension)
plqmihrmsk(wibrqqjunn) = vnzkyxoprm cuuscjcrin (kkzarjqjzf )
-
11 Feb 2022
plqmihrmsk(wibrqqjunn) = dgvdrdsuor cuuscjcrin (kkzarjqjzf )
Not Applicable
160
Low molecular weight (LMW) HA
mwurblxqwf(tpjtsktyvg) = improvement was detected by 1 month in 84.3% of cases, and remained until the end of the study in 71.1% of patients thiiofupdh (kyhbofbnxc )
-
02 Jun 2021
Medium molecular weight (MMW) HA
Not Applicable
-
100
hgsknzmszk(vouvfhsuon) = wotdzodbmn xlmrfykmfm (oawwjgfunx )
Positive
02 Jun 2021
hgsknzmszk(vouvfhsuon) = zujhkyehnu xlmrfykmfm (oawwjgfunx )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free